- $133.10bn
- $171.98bn
- $68.92bn
- 72
- 46
- 93
- 80
R2019 December 31st | 2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45,349 | 56,587 | 64,388 | 67,074 | 68,920 |
Cost of Revenue | |||||
Gross Profit | 10,751 | 8,928 | 12,491 | 13,668 | 12,089 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 40,435 | 58,485 | 59,901 | 61,570 | 65,359 |
Operating Profit | 4,914 | -1,898 | 4,487 | 5,504 | 3,561 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,152 | -2,353 | 5,109 | 6,117 | 3,836 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,731 | -2,928 | 4,145 | 5,327 | 3,380 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 5,537 | -3,519 | 3,864 | 5,197 | 3,195 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5,537 | -3,519 | 3,864 | 5,197 | 3,195 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.32 | -0.367 | 4.11 | 4.91 | 4.99 |
Dividends per Share |